Supramolecular nanofibrils inhibit cancer progression in vitro and in vivo

Advanced Healthcare Materials

Volumn 3, Issue 8, 2014, Pages 1217-1221

  Kuang, Yi ^a   Du, Xuewen ^a   Zhou, Jie ^a   Xu, Bing ^a  

^a BRANDEIS UNIVERSITY   (United States)

Author keywords

Anticancer; De novo amyloid; Inverse comorbidity; Nanofibrils; Supramolecular

Indexed keywords

EPIDEMIOLOGY; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; OLIGOMERS; SUPRAMOLECULAR CHEMISTRY;

ANTICANCER; CO MORBIDITIES; DE NOVO AMYLOID; NANO-FIBRILS; SUPRAMOLECULAR;

NANOFIBERS;

NANOFIBRIL; NANOPARTICLE; UNCLASSIFIED DRUG; DRUG CARRIER; NANOFIBER; PEPTIDE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BETA SHEET; CANCER INHIBITION; CIRCULAR DICHROISM; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESEARCH; DRUG STRUCTURE; DRUG SYNTHESIS; HELA CELL LINE; HUMAN; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLID TUMOR; THERMODYNAMICS; TUMOR XENOGRAFT; ANIMAL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; MOUSE; NEOPLASMS; NUDE MOUSE; XENOGRAFT;

ANIMALS; CELL SURVIVAL; DRUG CARRIERS; HELA CELLS; HUMANS; MICE; MICE, NUDE; NANOFIBERS; NEOPLASMS; PEPTIDES; TRANSPLANTATION, HETEROLOGOUS;

EID: 84906098025     PISSN: 21922640     EISSN: 21922659     Source Type: Journal    
DOI: 10.1002/adhm.201300645     Document Type: Article

References (24)

1. C. Eheman, S. J. Henley, R. Ballard-Barbash, E. J. Jacobs, M. J. Schymura, A. Noone, L. Pan, R. N. Anderson, J. E. Fulton, B. A. Kohler, A. Jemal, E. Ward, M. Plescia, L. A. G. Ries, B. K. Edwards, Cancer 2012, 118, 2338; anonymous, American Cancer Society, Atlanta 2012.
2. R. Brookmeyer, E. Johnson, K. Ziegler-Graham, H. M. Arrighi, Alzheimer's Dementia 2007, 3, 186.
3. J. A. Driver, A. Beiser, R. Au, B. E. Kreger, G. L. Splansky, T. Kurth, D. P. Kiel, K. P. Lu, S. Seshadri, P. A. Wolf, Br. Med. J. 2012, 344, 1442
4. C. M. Roe, M. I. Behrens, C. Xiong, J. P. Miller, J. C. Morris, Neurology 2005, 64, 895
5. R. Tabares-Seisdedos, N. Dumont, A. Baudot, J. M. Valderas, J. Climent, A. Valencia, B. Crespo-Facorro, E. Vieta, M. Gomez-Beneyto, S. Martinez, J. L. Rubenstein, Lancet Oncol. 2011, 12, 604.
6. T. Oda, G. M. Pasinetti, H. H. Osterburg, C. Anderson, S. A. Johnson, C. E. Finch, Biochem. Biophys. Res. Commun. 1994, 204, 1131.
7. M. Bucciantini, E. Giannoni, F. Chiti, F. Baroni, L. Formigli, J. S. Zurdo, N. Taddei, G. Ramponi, C. M. Dobson, M. Stefani, Nature 2002, 416, 507
8. C. M. Dobson, Nature 2003, 426, 884.
9. R. Kayed, E. Head, J. L. Thompson, T. M. McIntire, S. C. Milton, C. W. Cotman, C. G. Glabe, Science 2003, 300, 486.
10. Y. Kuang, B. Xu, Angew. Chem. Int. Ed. 2013, 52, 6944.
11. Y. Zhang, Y. Kuang, Y. A. Gao, B. Xu, Langmuir 2011, 27, 529.
12. M. Reches, E. Gazit, Science 2003, 300, 625.
13. M. L. Ma, Y. Kuang, Y. Gao, Y. Zhang, P. Gao, B. Xu, J. Am. Chem. Soc. 2010, 132, 2719.
14. N. J. Greenfield, Nat. Protoc. 2006, 1, 2876.
15. B. Palecz, J. Therm. Anal. Calorim. 1998, 54, 257.
16. M. T. Pastor, N. Kummerer, V. Schubert, A. Esteras-Chopo, C. G. Dotti, M. L. de la Paz, L. Serrano, J. Mol. Biol. 2008, 375, 695.
17. L. F. Lincz, Immunol. Cell Biol. 1998, 76, 1.
18. J. Fogh, J. M. Fogh, T. Orfeo, J. Natl. Cancer Inst. 1977, 59, 221.
19. J. E. Liebmann, J. A. Cook, C. Lipschultz, D. Teague, J. Fisher, J. B. Mitchell, Br. J. Cancer 1993, 68, 1104.
20. P. Q. Zhao, H. J. Wang, M. Yu, Z. Y. Liao, X. H. Wang, F. Zhang, W. Ji, B. Wu, J. H. Han, H. C. Zhang, H. Q. Wang, J. Chang, R. F. Niu, Eur. J. Pharm. Biopharm. 2012, 81, 248.
21. D. L. Hickman, J. Am. Assoc. Lab. Anim. Sci. 2007, 46, 111.
22. J. P. Griffin, J. O'Grady, The Textbook of Pharmaceutical Medicine, Wiley-Blackwell, Hoboken 2006.
23. Y. Kuang, D. Yuan, Y. Zhang, A. Kao, X. W. Du, B. Xu, RSC Adv. 2013, 3, 7704.
24. X. M. Li, X. W. Du, J. Y. Li, Y. Gao, Y. Pan, J. F. Shi, N. Zhou, B. Xu, Langmuir 2012, 28, 13512.